About Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
During the past decade, Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
According to Clinical.Site data, the most researched conditions in "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program" are
"Hemoglobinuria, Paroxysmal" (1 trials) and "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials). Many other conditions were trialed in "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program" in a lesser frequency.
Clinical Trials Intervention Types at Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
Most popular intervention types in "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "eculizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
The vast majority of trials in "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program" are
2 trials for "All" genders.
Clinical Trials Status at Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
Currently, there are NaN active trials in "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".